Katie Ellias, T1D Fund - Studio Interview | LSI Europe '24

T1D Fund is a venture philanthropy fund to create a market in T1D by using our strategic equity investments and disease expertise to convince venture capital, biotech, and pharma to align with our mission of curing T1D.

LSI USA ‘26 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

March 16th - 20th, 2026  Waldorf Astoria, Monarch Beach Register arrow